SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-079677
Filing Date
2023-09-27
Accepted
2023-09-26 21:08:00
Documents
16
Period of Report
2023-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea185608-8k_adialpharma.htm   iXBRL 8-K 34775
2 CONSENT OF MARCUM LLP ea185608ex23-1_adialpharma.htm EX-23.1 2221
3 REVISED SECTIONS OF THE 2022 FORM 10-K ea185608ex99-1_adialpharma.htm EX-99.1 357962
4 GRAPHIC ex99-1_001.jpg GRAPHIC 28256
  Complete submission text file 0001213900-23-079677.txt   715250

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adil-20230926.xsd EX-101.SCH 3497
6 XBRL DEFINITION FILE adil-20230926_def.xml EX-101.DEF 26516
7 XBRL LABEL FILE adil-20230926_lab.xml EX-101.LAB 36424
8 XBRL PRESENTATION FILE adil-20230926_pre.xml EX-101.PRE 25140
10 EXTRACTED XBRL INSTANCE DOCUMENT ea185608-8k_adialpharma_htm.xml XML 4989
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 231281661
SIC: 2834 Pharmaceutical Preparations